Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Chemcel Biotech IPO.
July 1, 2024 2:30:00 PM
Biopharma deal activity plummeted down to Earth in the second quarter, with just a handful of M&A transactions and IPOs studding the mostly dark skies. | The slow quarter follows an exciting first one ...
Published by : FierceBiotechJuly 3, 2024 10:46:56 PM
In the U.S., 80 new IPOs rolled out from January through June, hauling in $17.8 billion in proceeds, according to EY's Global IPO Trends Q2 2024. The increase in IPOs hit 27% and the amount of IPO ...
Published by : U.S. News & World Report on MSNJune 24, 2024 6:31:00 PM
Alumis Inc., a South San Francisco biotech company looking to take an experimental psoriasis drug into a late-stage study, could net as much as $316 million in an initial public offering, the company ...
Published by : The Business JournalsJune 28, 2024 7:05:00 PM
Alumis is debuting in an initial public offering Friday on the Nasdaq, though the $250 million IPO is less than its initial targeted raise of $274 million just days ago.
Published by : BioSpaceJuly 1, 2024 11:19:00 AM
Artiva Biotherapeutics has become the latest biotech to set out IPO ambitions for the summer, as the allogeneic natural killer (NK) cell therapy company pushes its lead program through automimmune ...
Published by : FierceBiotechJuly 1, 2024 7:21:00 PM
The IPO market closed out June with four deals, three of which raised $100+ million. In the pipeline, nine companies submitted initial filings, led by what could be the largest IPO of 2024 to date.
Published by : Seeking AlphaJune 28, 2024 1:45:00 PM
Alumis, an immunology drug developer on the cusp of Phase 3, will go public Friday in a smaller IPO than it originally projected. The Bay Area startup sold 13.12 million shares $ALMS at $16 apiece to ...
Published by : ENDPOINTS NEWSJune 24, 2024 7:10:00 PM
Alumis Inc. on Monday said it plans to offer 17.65 million shares at an estimated price range of $16 to $18 per share in its upcoming initial public offering. At the midpoint of its range, Alumis ...
Published by : MarketWatch on MSNChemcel Biotech Limited IPO stock listed today at a huge discount of around 68%. An Agro Chemicals manufacturer's fixed price IPO was priced at Rs 16 and closed for subscription on September 12.
Chemcel stock opened at its issue price of Rs 16 and then keeps falling all day. At one point the stock went down to its day low of Rs 4.75. Later the stock recovered a little and finally closed at Rs 5.25, around -68% from its issue price.
Most of the experts told investors not to apply in this IPO. The grey market premiums were running at Rs 2 to Rs 3 just before its listing.
Chemcel Biotech IPO Listing Date & Info:
IPO Listing Date: Monday, October 13, 2008
BSE Script Code: 533026
Listing in: 'B' Group of Securities
ISIN: INE213J01012
Issue Price: Rs 16/- Per Equity Share
Face Value: Rs 10/- Per Equity Share
IPO Allotment Status is now available online for Chemcel Biotech Limited IPO.
Chemcel Biotech IPO was open on September 09, 2008 and closed on September 12, 20.
The Chemcel Biotech IPO is proposed to open on September 9, 2008. The IPO application ends on September 12, 2008.
Retail investors can apply in the retail or non-institutional investor category from September 9, 2008 to September 12, 2008. The Chemcel Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Chemcel Biotech IPO will open for subscription on September 9, 2008. The public issue will close on September 12, 2008.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
DRHP
